Health Care & Life Sciences » Healthcare Provision | Thyrocare Technologies Ltd.

Thyrocare Technologies Ltd. | Mutual Funds

Mutual Funds that own Thyrocare Technologies Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Reliance Pharma Fund
1,930,292
3.59%
6,103
4.79%
08/31/2018
Reliance Tax Saver (ELSS) Fund
1,809,000
3.37%
0
1.12%
08/31/2018
Birla Sun Life '95 Fund
1,711,799
3.19%
0
0.92%
07/31/2018
DSP BlackRock Micro Cap Fund
1,133,247
2.11%
-353,521
1.29%
02/28/2018
656,895
1.22%
656,895
1.51%
12/31/2017
Sundaram S.M.I.L.E Fund
599,008
1.12%
0
3.27%
08/31/2018
Fidelity Funds SICAV - India Focus Fund
580,461
1.08%
-147,373
0.3%
03/31/2018
Nomura Asset India Equity Mother Fund
299,024
0.56%
75,449
0.27%
09/12/2017
Grandeur Peak Emerging Markets Opportunities Fund
248,644
0.46%
248,644
0.51%
04/30/2018
SBI Life Balanced Fund
238,849
0.45%
76,297
0.45%
12/31/2017

About Thyrocare Technologies

View Profile
Address
MIDC Turbhe
Navi Mumbai Maharashtra 400703
India
Employees -
Website http://www.thyrocare.com
Updated 09/14/2018
Thyrocare Technologies Ltd. engages in provison of indepedent diagnostic and pathological laboratory services. It operates through the following segments: Diagnostic Testing Services, Imaging Services and Others. The Imaging Services segment represents PET-CT scan and sale of radio pharmaceuticals used in imaging services.